Daria Junak-Handkiewicz

Gliwice Branch
Gliwice, SL, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

TSH Stimulation Methods are Associated with Comparable Outcomes in Radioiodine-Avid Metastatic Differentiated Thyroid Cancer: Single Center Retrospective Observational Study.

TSH Stimulation Methods are Associated with Comparable Outcomes in Radioiodine-Avid Metastatic Differentiated Thyroid Cancer: Single Center Retrospective Observational Study.

Journal: Thyroid : official journal of the American Thyroid Association

Published: May 14, 2026

Assessment of phenotypes in a unique group of RET proto-oncogene Y791F variant carriers in the Polish population.

Assessment of phenotypes in a unique group of RET proto-oncogene Y791F variant carriers in the Polish population.

Journal: Endokrynologia Polska

Published: April 19, 2026

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer.

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer.

Journal: Frontiers in endocrinology

Published: March 24, 2026

Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center.

Real-world study of lenvatinib in patients with radioiodine‑refractory thyroid cancer treated in a tertiary reference center.

Journal: Endokrynologia Polska

Published: November 17, 2025

Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications.

Germline Mutations in DNA Repair Genes in Patients with Pancreatic Neuroendocrine Neoplasms: Diagnostic and Therapeutic Implications.

Journal: Current oncology (Toronto, Ont.)

Published: September 23, 2025

Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel.

Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel.

Journal: Breast cancer research : BCR

Published: September 17, 2025

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

Journal: Nuclear medicine review. Central & Eastern Europe

Published: September 02, 2025

Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 27, 2025

Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancer.

Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancer.

Journal: NPJ breast cancer

Published: February 11, 2025

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2025

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of the Polish National Scientific Societies, 2024 Update.

Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of the Polish National Scientific Societies, 2024 Update.

Journal: Endokrynologia Polska

Published: December 02, 2024

Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.

Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 25, 2024

Showing 1-12 of 62

Last Updated: 09/26/2026